What schedule does Soma with codeine fall under?

Soma, the brand name for carisoprodol, is categorized under Schedule IV of the Controlled Substances Act. When combined with codeine, it typically falls under Schedule III. This classification is due to the fact that products containing a certain quantity of codeine in combination with other ingredients are subject to the lower level of control compared to drugs in Schedules I and II.

Schedule III drugs are defined as having a moderate to low potential for physical and psychological dependence. In the case of Soma with codeine, the presence of codeine contributes to its classification under this schedule; it indicates that while the product has therapeutic potential, it also carries risks of abuse and dependence, which justifies its regulation.

Therefore, Soma with codeine is placed in Schedule III, reflecting both its therapeutic use and the concerns associated with codeine. Understanding the schedules helps pharmacists and healthcare providers identify the regulations and restrictions applicable to prescribing and dispensing these medications.